A Metabolomic Analysis of Cirrhotic Ascites.

amino acids ascites cholesterol decompensated cirrhosis fatty acids metabolomics

Journal

Molecules (Basel, Switzerland)
ISSN: 1420-3049
Titre abrégé: Molecules
Pays: Switzerland
ID NLM: 100964009

Informations de publication

Date de publication:
20 Jun 2022
Historique:
received: 10 04 2022
revised: 26 05 2022
accepted: 16 06 2022
entrez: 24 6 2022
pubmed: 25 6 2022
medline: 28 6 2022
Statut: epublish

Résumé

Ascites is a common complication of decompensated liver cirrhosis, and yet relatively little is known about its biochemical composition. We conducted two metabolomic investigations, comparing the profile of ascites from 33 cirrhotic patients and postoperative peritoneal drainage fluid from 33 surgical patients (Experiment 1). The profile of paired ascites and plasma was also compared in 17 cirrhotic patients (Experiment 2). Gas chromatography−mass spectrometry-based metabolomics identified 29 metabolites that significantly characterized ascites fluid, whether postoperative drainage fluid or plasma were used as controls. Ten elevated amino acids (glutamine, proline, histidine, tyrosine, glycine, valine, threonine, methionine, lysine, phenylalanine) and seven diminished lipids (laurate, myristate, palmitate, oleate, vaccenate, stearate, cholesterol) largely comprised the cirrhotic ascites metabolomic phenotype that differed significantly (adjusted p < 0.002 to 0.03) from peritoneal drainage fluid or plasma. The pattern of upregulated amino acids in cirrhotic ascites did not indicate albumin proteolysis by peritoneal bacteria. Bidirectional clustering showed that the more severe the cirrhosis, the lower the lipid concentration in ascitic fluid. The metabolomic compartment of ascites in patients with decompensated cirrhosis is characterized by increased amino acids and decreased lipids. These novel findings have potential relevance for diagnostic purposes.

Identifiants

pubmed: 35745058
pii: molecules27123935
doi: 10.3390/molecules27123935
pmc: PMC9228447
pii:
doi:

Substances chimiques

Amino Acids 0
Cholesterol 97C5T2UQ7J

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Références

Cancers (Basel). 2020 Oct 01;12(10):
pubmed: 33019704
Blood Transfus. 2016 May;14(2):185-94
pubmed: 27177401
J Ethnopharmacol. 2019 Sep 15;241:112034
pubmed: 31226385
J Clin Invest. 1991 Apr;87(4):1431-41
pubmed: 2010553
Metabolites. 2020 Jan 28;10(2):
pubmed: 32012846
Chirality. 2010 Jan;22(1):77-87
pubmed: 19319989
FEBS Lett. 1975 Oct 15;58(1):134-7
pubmed: 1225573
Biol Pharm Bull. 2005 Mar;28(3):549-52
pubmed: 15744089
J Biol Chem. 1953 Jan;200(1):367-71
pubmed: 13034794
Ann Surg. 1980 Dec;192(6):738-42
pubmed: 7447527
Gastroenterol Jpn. 1981;16(1):64-70
pubmed: 7227760
J Chem Inf Comput Sci. 2001 Nov-Dec;41(6):1488-93
pubmed: 11749573
Biochem Med. 1975 May;13(1):40-5
pubmed: 1167165
Clin Med (Lond). 2018 Apr 1;18(Suppl 2):s60-s65
pubmed: 29700095
Clin Chim Acta. 1995 Jul 31;239(1):13-22
pubmed: 7586583
PeerJ. 2016 Jan 26;4:e1624
pubmed: 26823999
J Biol Chem. 1975 Mar 25;250(6):2333-8
pubmed: 234968
Drug Metab Pharmacokinet. 2009;24(4):300-7
pubmed: 19745557
J Hepatol. 1992 Mar;14(2-3):244-8
pubmed: 1500688
Hepatology. 2013 Jul;58(1):229-38
pubmed: 23463346
J Viral Hepat. 2015 Jul;22(7):617-24
pubmed: 25487531
Nat Rev Mol Cell Biol. 2016 Jul;17(7):451-9
pubmed: 26979502
J Mol Biol. 2001 Dec 14;314(5):955-60
pubmed: 11743713
J Hepatol. 2019 Jan;70(1):151-171
pubmed: 30266282
Intern Emerg Med. 2012 Oct;7 Suppl 3:S193-9
pubmed: 23073857
IUBMB Life. 2005 Dec;57(12):787-96
pubmed: 16393781
J Lipid Res. 1975 May;16(3):165-79
pubmed: 236351
J Hepatol. 2010 Sep;53(3):397-417
pubmed: 20633946
J Chromatogr. 1984 Aug 10;309(2):225-42
pubmed: 6434570
Enzyme Microb Technol. 2013 Apr 10;52(4-5):218-25
pubmed: 23540922
Pleura Peritoneum. 2020 May 12;5(2):20200113
pubmed: 32566728
Biochem Pharmacol. 2020 Oct;180:114171
pubmed: 32710968
Mol Cell Proteomics. 2014 Dec;13(12):3558-71
pubmed: 25271300
Mol Biosyst. 2014 Dec;10(12):3101-10
pubmed: 25209359
Eur J Clin Chem Clin Biochem. 1993 Feb;31(2):103-6
pubmed: 8096769
Acta Chir Scand Suppl. 1960;Suppl 261:1-128
pubmed: 13831292
Eur J Clin Nutr. 2016 Mar;70(3):306-12
pubmed: 26395436
Biochem Pharmacol. 2018 Oct;156:491-500
pubmed: 30243960
NMR Biomed. 1989 Jul;2(2):77-82
pubmed: 2641294
Cancers (Basel). 2021 Jun 10;13(12):
pubmed: 34200553
Metabolomics. 2017 Oct;13:
pubmed: 29430218
Scand J Clin Lab Invest. 1988 Oct;48(6):543-52
pubmed: 3217757
Metabolomics. 2009 Dec;5(4):435-458
pubmed: 20046865
Clin Mol Hepatol. 2013 Jun;19(2):99-104
pubmed: 23837133
Biol Pharm Bull. 2002 Jun;25(6):695-704
pubmed: 12081132
Metab Eng. 2017 May;41:39-45
pubmed: 28342964
J Nutr. 2000 Jul;130(7):1835S-40S
pubmed: 10867060
Adv Exp Med Biol. 2019;1140:613-633
pubmed: 31347075
Hepatology. 2009 Jun;49(6):2087-107
pubmed: 19475696
NMR Biomed. 2008 Jul;21(6):606-14
pubmed: 18205245

Auteurs

Diren Beyoğlu (D)

Arthur G. Zupko Institute for Systems Pharmacology and Pharmacogenomics, Arnold and Marie Schwartz College of Pharmacy and Health Sciences, Long Island University, Brooklyn, New York, NY 11201, USA.
Hepatology, Department of BioMedical Research, University of Bern, 3008 Bern, Switzerland.

Cedric Simillion (C)

Hoffmann-La Roche AG, 4070 Basel, Switzerland.

Federico Storni (F)

Department of Visceral Surgery and Medicine, Inselspital, University Hospital Bern, 3010 Bern, Switzerland.

Andrea De Gottardi (A)

Faculty of Biomedical Sciences, Università della Svizzera Italiana, 6900 Lugano, Switzerland.
Gastroenterology and Hepatology, Ente Ospedaliero Cantonale, 6500 Lugano, Switzerland.

Jeffrey R Idle (JR)

Arthur G. Zupko Institute for Systems Pharmacology and Pharmacogenomics, Arnold and Marie Schwartz College of Pharmacy and Health Sciences, Long Island University, Brooklyn, New York, NY 11201, USA.
Hepatology, Department of BioMedical Research, University of Bern, 3008 Bern, Switzerland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH